In the long battle against cancer, human beings have moved from chemotherapy and radiation to targeted drugs, and now to cell-based therapies.Among these innovations, CAR-T cell ...
Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...